Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes

Kazuo Nakamura, Sho Ichi Yamagishi, Hisashi Adachi, Yayoi Kurita-Nakamura, Takanori Matsui, Hiroyoshi Inoue

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Background: Pigment epithelium-derived factor (PEDF) inhibits endothelial cell injury. Further, serum levels of PEDF are elevated in the metabolic syndrome. These observations suggest that PEDF may be elevated as a counter-system against vascular cell damage in the metabolic syndrome. However, little is known about the regulation of PEDF in patients with diabetes. In order to clarify the determinants of serum PEDF, here, we examined the relationship between the 1-year changes in PEDF levels and those in anthropometric and metabolic variables in type 2 diabetic patients. Methods: Eighty-six consecutive outpatients with type 2 diabetes underwent a complete history and physical examination, determination of blood chemistries, and serum levels of PEDF at baseline and 1 year after. PEDF gene expression in cultured subcutaneous or omental adipocytes were analysed by quantitative real-time reverse transcription-polymerase chain reactions. Results: Multiple regression analyses revealed that waist circumference, triglycerides, creatinine, and TNF-α were independently associated with PEDF. Further, the percent changes in serum levels of PEDF during 1-year observational periods were positively correlated with those of BMI. In addition, PEDF mRNA levels in cultured adipocytes were increased in parallel to the BMI values of subjects from whom adipocytes were derived, especially in omental adipocytes. Conclusion: These results demonstrated that serum levels of PEDF were positively associated with metabolic components and TNF-α in Japanese patients with type 2 diabetes. Our present study suggests that PEDF may be generated from adipose tissues and play some role in visceral obesity in type 2 diabetic patients.

Original languageEnglish
Pages (from-to)52-56
Number of pages5
JournalDiabetes/Metabolism Research and Reviews
Volume25
Issue number1
DOIs
Publication statusPublished - 2009
Externally publishedYes

Fingerprint

Adiposity
Type 2 Diabetes Mellitus
Serum
Adipocytes
pigment epithelium-derived factor
Abdominal Obesity
Waist Circumference
Reverse Transcription
Physical Examination
Blood Vessels
Adipose Tissue
Creatinine
Triglycerides
Outpatients
Endothelial Cells
History
Regression Analysis

Keywords

  • Atherosclerosis
  • Diabetes
  • Obesity
  • PEDF

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. / Nakamura, Kazuo; Yamagishi, Sho Ichi; Adachi, Hisashi; Kurita-Nakamura, Yayoi; Matsui, Takanori; Inoue, Hiroyoshi.

In: Diabetes/Metabolism Research and Reviews, Vol. 25, No. 1, 2009, p. 52-56.

Research output: Contribution to journalArticle

Nakamura, Kazuo ; Yamagishi, Sho Ichi ; Adachi, Hisashi ; Kurita-Nakamura, Yayoi ; Matsui, Takanori ; Inoue, Hiroyoshi. / Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes. In: Diabetes/Metabolism Research and Reviews. 2009 ; Vol. 25, No. 1. pp. 52-56.
@article{b4766872148a428cab9f812a2d341263,
title = "Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes",
abstract = "Background: Pigment epithelium-derived factor (PEDF) inhibits endothelial cell injury. Further, serum levels of PEDF are elevated in the metabolic syndrome. These observations suggest that PEDF may be elevated as a counter-system against vascular cell damage in the metabolic syndrome. However, little is known about the regulation of PEDF in patients with diabetes. In order to clarify the determinants of serum PEDF, here, we examined the relationship between the 1-year changes in PEDF levels and those in anthropometric and metabolic variables in type 2 diabetic patients. Methods: Eighty-six consecutive outpatients with type 2 diabetes underwent a complete history and physical examination, determination of blood chemistries, and serum levels of PEDF at baseline and 1 year after. PEDF gene expression in cultured subcutaneous or omental adipocytes were analysed by quantitative real-time reverse transcription-polymerase chain reactions. Results: Multiple regression analyses revealed that waist circumference, triglycerides, creatinine, and TNF-α were independently associated with PEDF. Further, the percent changes in serum levels of PEDF during 1-year observational periods were positively correlated with those of BMI. In addition, PEDF mRNA levels in cultured adipocytes were increased in parallel to the BMI values of subjects from whom adipocytes were derived, especially in omental adipocytes. Conclusion: These results demonstrated that serum levels of PEDF were positively associated with metabolic components and TNF-α in Japanese patients with type 2 diabetes. Our present study suggests that PEDF may be generated from adipose tissues and play some role in visceral obesity in type 2 diabetic patients.",
keywords = "Atherosclerosis, Diabetes, Obesity, PEDF",
author = "Kazuo Nakamura and Yamagishi, {Sho Ichi} and Hisashi Adachi and Yayoi Kurita-Nakamura and Takanori Matsui and Hiroyoshi Inoue",
year = "2009",
doi = "10.1002/dmrr.820",
language = "English",
volume = "25",
pages = "52--56",
journal = "Diabetes/Metabolism Research and Reviews",
issn = "1520-7552",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Serum levels of pigment epithelium-derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes

AU - Nakamura, Kazuo

AU - Yamagishi, Sho Ichi

AU - Adachi, Hisashi

AU - Kurita-Nakamura, Yayoi

AU - Matsui, Takanori

AU - Inoue, Hiroyoshi

PY - 2009

Y1 - 2009

N2 - Background: Pigment epithelium-derived factor (PEDF) inhibits endothelial cell injury. Further, serum levels of PEDF are elevated in the metabolic syndrome. These observations suggest that PEDF may be elevated as a counter-system against vascular cell damage in the metabolic syndrome. However, little is known about the regulation of PEDF in patients with diabetes. In order to clarify the determinants of serum PEDF, here, we examined the relationship between the 1-year changes in PEDF levels and those in anthropometric and metabolic variables in type 2 diabetic patients. Methods: Eighty-six consecutive outpatients with type 2 diabetes underwent a complete history and physical examination, determination of blood chemistries, and serum levels of PEDF at baseline and 1 year after. PEDF gene expression in cultured subcutaneous or omental adipocytes were analysed by quantitative real-time reverse transcription-polymerase chain reactions. Results: Multiple regression analyses revealed that waist circumference, triglycerides, creatinine, and TNF-α were independently associated with PEDF. Further, the percent changes in serum levels of PEDF during 1-year observational periods were positively correlated with those of BMI. In addition, PEDF mRNA levels in cultured adipocytes were increased in parallel to the BMI values of subjects from whom adipocytes were derived, especially in omental adipocytes. Conclusion: These results demonstrated that serum levels of PEDF were positively associated with metabolic components and TNF-α in Japanese patients with type 2 diabetes. Our present study suggests that PEDF may be generated from adipose tissues and play some role in visceral obesity in type 2 diabetic patients.

AB - Background: Pigment epithelium-derived factor (PEDF) inhibits endothelial cell injury. Further, serum levels of PEDF are elevated in the metabolic syndrome. These observations suggest that PEDF may be elevated as a counter-system against vascular cell damage in the metabolic syndrome. However, little is known about the regulation of PEDF in patients with diabetes. In order to clarify the determinants of serum PEDF, here, we examined the relationship between the 1-year changes in PEDF levels and those in anthropometric and metabolic variables in type 2 diabetic patients. Methods: Eighty-six consecutive outpatients with type 2 diabetes underwent a complete history and physical examination, determination of blood chemistries, and serum levels of PEDF at baseline and 1 year after. PEDF gene expression in cultured subcutaneous or omental adipocytes were analysed by quantitative real-time reverse transcription-polymerase chain reactions. Results: Multiple regression analyses revealed that waist circumference, triglycerides, creatinine, and TNF-α were independently associated with PEDF. Further, the percent changes in serum levels of PEDF during 1-year observational periods were positively correlated with those of BMI. In addition, PEDF mRNA levels in cultured adipocytes were increased in parallel to the BMI values of subjects from whom adipocytes were derived, especially in omental adipocytes. Conclusion: These results demonstrated that serum levels of PEDF were positively associated with metabolic components and TNF-α in Japanese patients with type 2 diabetes. Our present study suggests that PEDF may be generated from adipose tissues and play some role in visceral obesity in type 2 diabetic patients.

KW - Atherosclerosis

KW - Diabetes

KW - Obesity

KW - PEDF

UR - http://www.scopus.com/inward/record.url?scp=65549162987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549162987&partnerID=8YFLogxK

U2 - 10.1002/dmrr.820

DO - 10.1002/dmrr.820

M3 - Article

VL - 25

SP - 52

EP - 56

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

IS - 1

ER -